FDA Inspection 1217654 — Eagle Labs, Inc.

Eagle Labs, Inc. — FEI 3020295319

The FDA completed an inspection of Eagle Labs, Inc. on August 24, 2023 in Oldsmar, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 24, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Oldsmar, FL (United States)